[email protected] +91 9789129171
IWCGPM · Registering as Listener

International Workshop on Cardiovascular Genetics and Precision Medicine

11 - 12 Feb 2027 Stavanger, Norway Standard / Physical Participation
Listener Registration
$115
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceIWCGPM
ModeStandard / Physical
ParticipationListener
Registration fee$175.00
Bank charges (5.8%)$10.15
Total payable$185.15
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

IWCGPM conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Advancements in Cardiovascular Genetics +
This track will explore recent breakthroughs in the field of cardiovascular genetics, focusing on the identification of genetic variants associated with heart disease. Participants will discuss the implications of these findings for risk assessment and disease prevention.
02 Precision Medicine in Cardiology +
This session will delve into the application of precision medicine in cardiology, highlighting personalized treatment strategies based on genetic and phenotypic data. Attendees will examine case studies that demonstrate the effectiveness of tailored therapies in improving patient outcomes.
03 Genomic Medicine and Cardiovascular Disease +
Focusing on the integration of genomic medicine into cardiovascular care, this track will discuss how genomic information can inform clinical decision-making. Presentations will cover the role of genomics in understanding disease mechanisms and guiding therapeutic interventions.
04 Translational Research in Cardiac Genetics +
This session will highlight the translation of genetic research findings into clinical practice for cardiovascular diseases. Participants will share innovative approaches to bridging the gap between laboratory discoveries and patient care.
05 Emerging Biomarkers in Cardiovascular Health +
This track will focus on the discovery and validation of novel biomarkers for cardiovascular diseases, emphasizing their potential role in early diagnosis and monitoring. Discussions will include the challenges and opportunities in biomarker research.
06 Ethical Considerations in Cardiovascular Genomics +
This session will address the ethical implications of genetic testing and genomic research in cardiology. Experts will discuss issues related to consent, privacy, and the equitable distribution of genomic technologies.
07 Innovations in Cardiovascular Imaging +
This track will showcase cutting-edge imaging technologies that enhance the understanding of cardiovascular genetics and disease. Presentations will highlight how advanced imaging techniques can aid in the diagnosis and management of heart conditions.
08 Lifestyle and Genetic Interactions in Heart Disease +
This session will explore the interplay between genetic predispositions and lifestyle factors in the development of cardiovascular diseases. Researchers will present findings that illustrate how lifestyle modifications can mitigate genetic risks.
09 Pharmacogenomics in Cardiovascular Therapy +
Focusing on pharmacogenomics, this track will discuss how genetic variations influence drug responses in cardiovascular treatments. Participants will examine the potential for personalized medication regimens to enhance therapeutic efficacy and reduce adverse effects.
10 Population Genetics and Cardiovascular Disease +
This session will investigate the role of population genetics in understanding the epidemiology of cardiovascular diseases. Discussions will include the impact of genetic diversity on disease prevalence and treatment responses across different populations.
11 Future Directions in Cardiovascular Research +
This track will provide insights into the future of cardiovascular research, emphasizing emerging trends and technologies in the field. Experts will discuss the potential impact of artificial intelligence and big data on cardiovascular genetics and precision medicine.